News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mela Sciences (MELA) a Leader in the Fight Against Melanoma, to Release Second Quarter 2013 Financial Results and Host Conference Call on Wednesday, August 7, 2013


7/18/2013 9:27:22 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINGTON, N.Y., July 17, 2013 (GLOBE NEWSWIRE) -- MELA Sciences, Inc. (Nasdaq:MELA), the medical device company that has developed and is commercializing MelaFind®, the first and only FDA approved optical diagnostic device for melanoma detection used by dermatologists in their fight against melanoma, today announced that it will release its 2013 second quarter financial results after the close of trading on Wednesday, August 7, 2013. MELA Sciences' executives will also host a conference call that day at 4:30 PM ET to discuss the results, as well as provide a general business update.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES